Literature DB >> 34606009

Age-related changes and reference intervals of RANKL, OPG, and bone turnover markers in Indian women.

Sandhya Nair1, Sonam Hatkar1, Anushree Patil2, Suchitra Surve2, Beena Joshi3, Nafisa Balasinor4, Meena Desai5.   

Abstract

RANKL and OPG are cytokines involved in bone remodeling that makes them potential bone biomarkers. The reference interval for these cytokines, their ratio, and bone turnover markers CTX and PINP were established in Indian women, which may serve in diagnosis and management of osteoporosis.
PURPOSE: The aim of the study was to establish reference interval for RANKL, OPG, RANKL/OPG, and bone turnover markers CTX and PINP in healthy Indian women.
METHODS: This was a cross-sectional study on 374 healthy Indian women in the age group of 20-65 years. Serum levels of total RANKL, OPG, CTX, PINP, and estradiol were determined by commercial ELISA kits. The reference intervals for these cytokines and bone turnover markers were based on the 95% centrally distributed data.
RESULTS: Median RANKL (245.6 pmol/L vs. 149 pmol/L) and RANKL/OPG (38.7 vs. 20.4) were higher, while sCTX (380 ng/L vs. 551 ng/L) and OPG levels (6.1 pmol/L vs. 7.4 pmol/L) were lower in premenopausal women than those in postmenopausal women. PINP levels were comparable in both groups. Women were classified into 5 groups according to decades of age and the reference intervals for RANKL, OPG, RANKL/OPG ratio, and CTX and PINP in each group were reported.
CONCLUSION: We reported menopausal status-based and age-related reference intervals for serum RANKL, OPG, RANKL/OPG ratio, and CTX and PINP in healthy Indian women.
© 2021. International Osteoporosis Foundation and National Osteoporosis Foundation.

Entities:  

Keywords:  BMD; CTX; OPG; PINP; RANKL

Mesh:

Substances:

Year:  2021        PMID: 34606009     DOI: 10.1007/s11657-021-01014-4

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  25 in total

1.  Monitoring individual response to hormone replacement therapy with bone markers.

Authors:  P D Delmas; P Hardy; P Garnero; M Dain
Journal:  Bone       Date:  2000-06       Impact factor: 4.398

Review 2.  Regulation of osteoclast formation and function.

Authors:  L T Duong; G A Rodan
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 3.  Bone turnover markers: use in osteoporosis.

Authors:  Kim Naylor; Richard Eastell
Journal:  Nat Rev Rheumatol       Date:  2012-06-05       Impact factor: 20.543

Review 4.  Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.

Authors:  T Suda; N Takahashi; N Udagawa; E Jimi; M T Gillespie; T J Martin
Journal:  Endocr Rev       Date:  1999-06       Impact factor: 19.871

5.  Age-related changes in bone turnover markers and ovarian hormones in premenopausal and postmenopausal Indian women.

Authors:  Meena P Desai; K V Bhanuprakash; M Ikram Khatkhatay; Uday M Donde
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

Review 6.  Sex steroids and the construction and conservation of the adult skeleton.

Authors:  B Lawrence Riggs; Sundeep Khosla; L Joseph Melton
Journal:  Endocr Rev       Date:  2002-06       Impact factor: 19.871

7.  The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study.

Authors:  Anna Stern; Gail A Laughlin; Jaclyn Bergstrom; Elizabeth Barrett-Connor
Journal:  Eur J Endocrinol       Date:  2007-05       Impact factor: 6.664

Review 8.  Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis.

Authors:  Samuel D Vasikaran
Journal:  Crit Rev Clin Lab Sci       Date:  2008       Impact factor: 6.250

9.  Soluble RANKL and risk of nontraumatic fracture.

Authors:  Georg Schett; Stefan Kiechl; Kurt Redlich; Friedrich Oberhollenzer; Siegfried Weger; Georg Egger; Agnes Mayr; Josef Jocher; Qingbo Xu; Peter Pietschmann; Steven Teitelbaum; Josef Smolen; Johann Willeit
Journal:  JAMA       Date:  2004-03-03       Impact factor: 56.272

10.  OPG and sRANKL serum levels and incident hip fracture in postmenopausal Caucasian women in the Women's Health Initiative Observational Study.

Authors:  Andrea Z LaCroix; Rebecca D Jackson; Aaron Aragaki; Charles Kooperberg; Jane A Cauley; Zhao Chen; Meryl S Leboff; David Duggan; Jean Wactawski-Wende
Journal:  Bone       Date:  2013-06-02       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.